PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary embolism |
| Phenotype | C0007120|alveolar cell carcinoma |
| Sentences | 1 |
| PubMedID- 22743083 | Of patients who developed cavitytotalp valuegender0.41 male22729 female36743tumor stage0.48 ia213 ib303 iia011 iib101 iiia314 iiib415 iv451055tumor histology1.00 adenocarcinoma48a12b60 large cell carcinoma202 nsclc (not otherwise specified)8210radiation therapy1.00 prior to bevacizumab therapy22527 concurrent101 none35944smoking0.13 never15419 current15722 former28331adverse events hypertension115160.28 skin rashd8190.68 proteinuriad2021.00 hemoptysisd4c1c51.00 epistaxisd153181.00 gastrointestinal bleedingd1120.36 deep venous thrombosis or pulmonary embolism3141.00ainclude patients with bronchioalveolar cell carcinoma subtype (n = 4).binclude patients with bronchioalveolar cell carcinoma subtype (n = 1).call 5 patients had grade 1 hemoptysis.din 2 patients, the status of the adverse events was unknown.table 2therapeutic regimen using bevacizumab in 72 eligible patientstherapeutic regimenno. |
Page: 1